ctx130
crispr therapeutics ag
['ctx130', 'cobalt,rcc', 'crispr']
superstar presents on phase 1 cobalt-rcc study of ctx130, an allogeneic crispr/cas9 edited cd70 #cartcell for #renalcellcarcinoma was safe with 1 cr noted for over 18 months #sitc22 